Clinical Trial

Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Long-term extension of a multi-site, first-in-human study to assess safety and efficacy of an active implantable Vagus Nerve Stimulation (VNS) device in adult patients with active moderate-to-severe rheumatoid arthritis who have had an incomplete response or intolerability to at least two biologic and/or targeted synthetic DMARDs having at least two different mechanisms of action
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-04-22.
Trial Details
NCT Number NCT04862117
Lead Sponsor SetPoint Medical Corporation
Conditions Rheumatoid Arthritis
Enrollment 14 participants
Start Date 2018-07-28
Primary Completion 2026-12-08 (estimated)
Study Completion 2026-12-08 (estimated)
Updated on ClinicalTrials.gov 2025-05-13